Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisome proliferator–activated receptor gamma (PPARγ) is a ligand-activated transcription factor belonging to the nuclear receptor superfamily. It plays a central role in regulating gene expression related to metabolism, adipogenesis, insulin sensitivity, inflammation, and fluid homeostasis. Activation or modulation of PPARγ has therapeutic implications for metabolic diseases including type II diabetes mellitus due to its role in improving insulin sensitivity. It may also be relevant for inflammatory conditions given its regulatory effects on immune cells like macrophages.
Activation of PPARγ leads to changes in gene expression related to metabolism, adipogenesis, insulin sensitivity, inflammation, and fluid homeostasis. Synthetic agonists like thiazolidinediones improve insulin sensitivity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisome proliferator–activated receptor gamma (PPARγ).